In all, the current study indicated that MALAT1 up-regulation might be a valuable biomarker for the distant metastasis in gastric cancer patients, and miR-122-IGF-1R signaling might be involved in the MALAT1 dysregulation in gastric cancer. Here, IGF1R is linked to gastric cancer.